Article

Surface Expression of CD63 and HLA-DR in circulating eosinophils correlates with Improved Clinical Control After Treatment Optimization in asthma

2025-11-28

Abstract excerpt

<title>Abstract</title> <p>Background Eosinophils are key effectors in asthma, especially within the T2-high phenotype. Conventional biomarkers such as blood eosinophils, FeNO, and IgE incompletely reflect disease activity. Surface markers like CD63 and HLA-DR might provide additional insight into eosinophil activation and treatment response. Objective To evaluate whether CD63 and HLA-DR expression on circulating...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3ac91a2f-645e-5b95-ba60-ec1d6f35b71b
DOI: 10.21203/rs.3.rs-7923148/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Surface Expression of CD63 and HLA-DR in circulating eosinophils correlates with Improved Clinical Control After Treatment Optimization in asthmaDOI 10.21203/rs.3.rs-7923148/v1Read

Single cell RNA-seq discovery of blood biomarkers predicting treatment outcome in severe asthma patientsSemantic proximity Read

Eosinophil Counts in Adults with Asthma Treated with Anti-IL-4Rα Rademikibart in a Randomized TrialSemantic proximity Read

The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic AsthmaSemantic proximity Read

HLA-G Haplotypes Are Differentially Associated with Asthmatic FeaturesSemantic proximity Read

Expanded peripheral CD62Llow inflammatory eosinophils in pediatric thunderstorm-related asthma exacerbations: A single-center analysis.Semantic proximity Read

Monitoring eosinophils to guide therapy with Biologics in Asthma: does the compartment matter?Semantic proximity Read

¿p#1 Multidomain Clinical and Biological Remission with Tezepelumab in Severe Asthma: A 12-Month Multicentre Real-World StudySemantic proximity Read

Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.Semantic proximity Read

Investigating simultaneous effect of CCR3 Receptor Antagonist therapy and Mesenchymal Stem Cells (MSC) transduced with eosinophil suppressor tetrapeptide protein, SP-A as cell therapy in Allergic AsthmaSemantic proximity Read

Peripheral blood gene expression predicts clinical benefit from anti–IL-13 in asthmaSemantic proximity Read

Mobilisation of HLA-F on the surface of bronchial epithelial cells and platelets in asthmatic patients.Semantic proximity Read

Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants.Semantic proximity Read